The selective delivery of chemotherapeutic agents to their site of action should increase therapeutic effectiveness and limit side effects. Most drug therapies currently available, however, exhibit little, if any specificity. Many times, a drug has limited or no access to its intended site of action or is prematurely metabolized or excreted. In other instances, the drug travels rather freely throughout the body and not only acts on the desired target tissues but also causes undesirable effects on nontarget tissues. This lack of target specificity is attributable, for the most part, to the formidable barriers that the body presents to the successful delivery of a drug from its site of administration to its site of action: a drug normally encounters or must by pass various molecules, enzymes, cells, membranes, and organs before reaching its designated target.
This report aims to provide a comprehensive presentation of the global market for Site-Specific Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Site-Specific Drug Delivery. This report contains market size and forecasts of Site-Specific Drug Delivery in global, including the following market information:
- Global Site-Specific Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Site-Specific Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Site-Specific Drug Delivery in US$ by following Product Segments.: Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel and other.
Company profiles are primarily based on public domain information including company
- Johnson & Johnson
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Luye Pharma
- Sigma-Tau Group
- Fudan-Zhangjiang
- Teva Pharmaceutical
- CSPC
- Novartis
- Kingond Pharm
We surveyed the Site-Specific Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Site-Specific Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Site-Specific Drug Delivery Market Segment Percentages, by Type, 2022 (%)
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Other
Global Site-Specific Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Site-Specific Drug Delivery Market Segment Percentages, by Application, 2022 (%)
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Other
Global Site-Specific Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Site-Specific Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Site-Specific Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Site-Specific Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Luye Pharma
- Sigma-Tau Group
- Fudan-Zhangjiang
- Teva Pharmaceutical
- CSPC
- Novartis
- Kingond Pharm
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Site-Specific Drug Delivery, market overview.
- Chapter 2: Global Site-Specific Drug Delivery market size in revenue.
- Chapter 3: Detailed analysis of Site-Specific Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Site-Specific Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Site-Specific Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Site-Specific Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Site-Specific Drug Delivery Overall Market Size
2.1 Global Site-Specific Drug Delivery Market Size: 2022 VS 2029
2.2 Global Site-Specific Drug Delivery Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Site-Specific Drug Delivery Players in Global Market
3.2 Top Global Site-Specific Drug Delivery Companies Ranked by Revenue
3.3 Global Site-Specific Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Site-Specific Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Site-Specific Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Site-Specific Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Site-Specific Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Site-Specific Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Site-Specific Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Liposomal Doxorubicin
4.1.3 Liposomal Amphoteracin B
4.1.4 Liposomal Paclitaxel
4.1.5 Other
4.2 By Type - Global Site-Specific Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Site-Specific Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Site-Specific Drug Delivery Revenue, 2024-2029
4.2.3 By Type - Global Site-Specific Drug Delivery Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Site-Specific Drug Delivery Market Size, 2022 & 2029
5.1.2 Fungal Infection Therapy
5.1.3 Cancer & Tumor Therapy
5.1.4 Other
5.2 By Application - Global Site-Specific Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Site-Specific Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Site-Specific Drug Delivery Revenue, 2024-2029
5.2.3 By Application - Global Site-Specific Drug Delivery Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Site-Specific Drug Delivery Market Size, 2022 & 2029
6.2 By Region - Global Site-Specific Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Site-Specific Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Site-Specific Drug Delivery Revenue, 2024-2029
6.2.3 By Region - Global Site-Specific Drug Delivery Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Site-Specific Drug Delivery Revenue, 2018-2029
6.3.2 US Site-Specific Drug Delivery Market Size, 2018-2029
6.3.3 Canada Site-Specific Drug Delivery Market Size, 2018-2029
6.3.4 Mexico Site-Specific Drug Delivery Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Site-Specific Drug Delivery Revenue, 2018-2029
6.4.2 Germany Site-Specific Drug Delivery Market Size, 2018-2029
6.4.3 France Site-Specific Drug Delivery Market Size, 2018-2029
6.4.4 U.K. Site-Specific Drug Delivery Market Size, 2018-2029
6.4.5 Italy Site-Specific Drug Delivery Market Size, 2018-2029
6.4.6 Russia Site-Specific Drug Delivery Market Size, 2018-2029
6.4.7 Nordic Countries Site-Specific Drug Delivery Market Size, 2018-2029
6.4.8 Benelux Site-Specific Drug Delivery Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Site-Specific Drug Delivery Revenue, 2018-2029
6.5.2 China Site-Specific Drug Delivery Market Size, 2018-2029
6.5.3 Japan Site-Specific Drug Delivery Market Size, 2018-2029
6.5.4 South Korea Site-Specific Drug Delivery Market Size, 2018-2029
6.5.5 Southeast Asia Site-Specific Drug Delivery Market Size, 2018-2029
6.5.6 India Site-Specific Drug Delivery Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Site-Specific Drug Delivery Revenue, 2018-2029
6.6.2 Brazil Site-Specific Drug Delivery Market Size, 2018-2029
6.6.3 Argentina Site-Specific Drug Delivery Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Site-Specific Drug Delivery Revenue, 2018-2029
6.7.2 Turkey Site-Specific Drug Delivery Market Size, 2018-2029
6.7.3 Israel Site-Specific Drug Delivery Market Size, 2018-2029
6.7.4 Saudi Arabia Site-Specific Drug Delivery Market Size, 2018-2029
6.7.5 UAE Site-Specific Drug Delivery Market Size, 2018-2029
7 Site-Specific Drug Delivery Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Site-Specific Drug Delivery Major Product Offerings
7.1.4 Johnson & Johnson Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Site-Specific Drug Delivery Major Product Offerings
7.2.4 Gilead Sciences Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Pacira
7.3.1 Pacira Company Summary
7.3.2 Pacira Business Overview
7.3.3 Pacira Site-Specific Drug Delivery Major Product Offerings
7.3.4 Pacira Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Pacira Key News & Latest Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Site-Specific Drug Delivery Major Product Offerings
7.4.4 Sun Pharmaceutical Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Sun Pharmaceutical Key News & Latest Developments
7.5 Luye Pharma
7.5.1 Luye Pharma Company Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Site-Specific Drug Delivery Major Product Offerings
7.5.4 Luye Pharma Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 Luye Pharma Key News & Latest Developments
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Company Summary
7.6.2 Sigma-Tau Group Business Overview
7.6.3 Sigma-Tau Group Site-Specific Drug Delivery Major Product Offerings
7.6.4 Sigma-Tau Group Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 Sigma-Tau Group Key News & Latest Developments
7.7 Fudan-Zhangjiang
7.7.1 Fudan-Zhangjiang Company Summary
7.7.2 Fudan-Zhangjiang Business Overview
7.7.3 Fudan-Zhangjiang Site-Specific Drug Delivery Major Product Offerings
7.7.4 Fudan-Zhangjiang Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Fudan-Zhangjiang Key News & Latest Developments
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Site-Specific Drug Delivery Major Product Offerings
7.8.4 Teva Pharmaceutical Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Teva Pharmaceutical Key News & Latest Developments
7.9 CSPC
7.9.1 CSPC Company Summary
7.9.2 CSPC Business Overview
7.9.3 CSPC Site-Specific Drug Delivery Major Product Offerings
7.9.4 CSPC Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 CSPC Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Site-Specific Drug Delivery Major Product Offerings
7.10.4 Novartis Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Kingond Pharm
7.11.1 Kingond Pharm Company Summary
7.11.2 Kingond Pharm Business Overview
7.11.3 Kingond Pharm Site-Specific Drug Delivery Major Product Offerings
7.11.4 Kingond Pharm Site-Specific Drug Delivery Revenue in Global Market (2018-2023)
7.11.5 Kingond Pharm Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Site-Specific Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Site-Specific Drug Delivery Market Drivers in Global Market
Table 3. Site-Specific Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Site-Specific Drug Delivery in Global Market
Table 5. Top Site-Specific Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Site-Specific Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Site-Specific Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Site-Specific Drug Delivery Product Type
Table 9. List of Global Tier 1 Site-Specific Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Site-Specific Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Site-Specific Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Site-Specific Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Site-Specific Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Site-Specific Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Site-Specific Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Site-Specific Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Site-Specific Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Site-Specific Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Site-Specific Drug Delivery Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Site-Specific Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Site-Specific Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Site-Specific Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Site-Specific Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Site-Specific Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Site-Specific Drug Delivery Product Offerings
Table 32. Johnson & Johnson Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Site-Specific Drug Delivery Product Offerings
Table 36. Gilead Sciences Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Pacira Company Summary
Table 39. Pacira Site-Specific Drug Delivery Product Offerings
Table 40. Pacira Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. Pacira Key News & Latest Developments
Table 42. Sun Pharmaceutical Company Summary
Table 43. Sun Pharmaceutical Site-Specific Drug Delivery Product Offerings
Table 44. Sun Pharmaceutical Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. Sun Pharmaceutical Key News & Latest Developments
Table 46. Luye Pharma Company Summary
Table 47. Luye Pharma Site-Specific Drug Delivery Product Offerings
Table 48. Luye Pharma Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. Luye Pharma Key News & Latest Developments
Table 50. Sigma-Tau Group Company Summary
Table 51. Sigma-Tau Group Site-Specific Drug Delivery Product Offerings
Table 52. Sigma-Tau Group Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. Sigma-Tau Group Key News & Latest Developments
Table 54. Fudan-Zhangjiang Company Summary
Table 55. Fudan-Zhangjiang Site-Specific Drug Delivery Product Offerings
Table 56. Fudan-Zhangjiang Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Fudan-Zhangjiang Key News & Latest Developments
Table 58. Teva Pharmaceutical Company Summary
Table 59. Teva Pharmaceutical Site-Specific Drug Delivery Product Offerings
Table 60. Teva Pharmaceutical Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Pharmaceutical Key News & Latest Developments
Table 62. CSPC Company Summary
Table 63. CSPC Site-Specific Drug Delivery Product Offerings
Table 64. CSPC Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 65. CSPC Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Site-Specific Drug Delivery Product Offerings
Table 68. Novartis Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Kingond Pharm Company Summary
Table 71. Kingond Pharm Site-Specific Drug Delivery Product Offerings
Table 72. Kingond Pharm Site-Specific Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 73. Kingond Pharm Key News & Latest Developments
List of Figures
Figure 1. Site-Specific Drug Delivery Segment by Type in 2022
Figure 2. Site-Specific Drug Delivery Segment by Application in 2022
Figure 3. Global Site-Specific Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Site-Specific Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Site-Specific Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Site-Specific Drug Delivery Revenue in 2022
Figure 8. By Type - Global Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 9. By Application - Global Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 10. By Type - Global Site-Specific Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 12. By Application - Global Site-Specific Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 14. By Region - Global Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Country - North America Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 16. US Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 20. Germany Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 21. France Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 28. China Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. India Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 34. Brazil Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Site-Specific Drug Delivery Revenue Market Share, 2018-2029
Figure 37. Turkey Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Site-Specific Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. Johnson & Johnson Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pacira Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sun Pharmaceutical Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Luye Pharma Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sigma-Tau Group Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Fudan-Zhangjiang Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Pharmaceutical Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. CSPC Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novartis Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Kingond Pharm Site-Specific Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
